logo

MBOT

Microbot Medical·NASDAQ
--
--(--)
--
--(--)
4.27 / 10
Netural

With a fund flow rating of 7.53/10, the stock shows robust fund flow characteristics. Supportive momentum from no significant trends trends is partially offset by concerning overall, block, Small, Medium, Large, and Extra-large patterns, pointing to positive capital flow trajectory. Analyst perspective reveals overwhelmingly bullish analyst consensus with strong conviction. Rating breakdown: Strong Buy(100.0%) from 2 analyst assessments, supported by 1.01 historical weighted rating.

FundamentalSentiment(4.27)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

100%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2025-12-03
InstitutionRoth Capital
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of MBOT?
  • MBOT holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.27/10 (Netural).